Left Ventricular Ejection Fraction Assessment Among Patients With Acute Myocardial Infarction and Its Association With Hospital Quality of Care and Evidence-Based Therapy Use
暂无分享,去创建一个
M. Funk | E. Amsterdam | Tracy Y. Wang | J. Saucedo | A. Chen | Chadi Dib | Amy Miller | Li Li
[1] J. McMurray,et al. Eplerenone in patients with systolic heart failure and mild symptoms. , 2011, The New England journal of medicine.
[2] A. Yan,et al. Evaluation of left ventricular ejection fraction in non-ST-segment elevation acute coronary syndromes and its relationship to treatment. , 2010, American heart journal.
[3] L. Schwamm,et al. Hospital performance recognition with the Get With The Guidelines Program and mortality for acute myocardial infarction and heart failure. , 2009, American heart journal.
[4] Li Liang,et al. Predictors of cardiac rehabilitation referral in coronary artery disease patients: findings from the American Heart Association's Get With The Guidelines Program. , 2009, Journal of the American College of Cardiology.
[5] J. Gore,et al. Trends in the use of echocardiography and left ventriculography to assess left ventricular ejection fraction in patients hospitalized with acute myocardial infarction. , 2009, American heart journal.
[6] C. Cannon,et al. Current use of beta blockers in patients with reactive airway disease who are hospitalized with acute coronary syndromes. , 2009, The American journal of cardiology.
[7] C. Yancy,et al. Influence of hospital length of stay for heart failure on quality of care. , 2008, The American journal of cardiology.
[8] Harlan M Krumholz,et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemaker , 2008, Circulation.
[9] Harlan M Krumholz,et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemaker , 2008, Journal of the American College of Cardiology.
[10] J. Gore,et al. Changing trends in the evaluation of ejection fraction in patients hospitalized with acute myocardial infarction: the Worcester Heart Attack Study. , 2008, American heart journal.
[11] Adnan Kastrati,et al. Evolution of left ventricular ejection fraction and its relationship to infarct size after acute myocardial infarction. , 2007, Journal of the American College of Cardiology.
[12] C. Yancy,et al. Get with the guidelines steering committee and hospitals, sex and racial differences in the use of implantable cardioverter & defibrillators among patients hospitalized with heart failure , 2007 .
[13] Harlan M Krumholz,et al. ACC/AHA clinical performance measures for adults with ST-elevation and non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures on ST-Elevation and Non-ST-El , 2006, Journal of the American College of Cardiology.
[14] Harlan M Krumholz,et al. ACC/AHA Clinical Performance Measures for Adults with Chronic Heart Failure: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Heart Failure Clinical Performance Measures): endorsed by the Heart Failure Society , 2005, Circulation.
[15] S. Solomon,et al. Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. , 2005, The New England journal of medicine.
[16] G. Lamas,et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1999 guidelines for the management of patients wi , 2004, Journal of the American College of Cardiology.
[17] V. Roger,et al. Measurement of ejection fraction after myocardial infarction in the population. , 2004, Chest.
[18] B. Pitt,et al. Eplerenone , a Selective Aldosterone Blocker , in Patients with Left Ventricular Dysfunction after Myocardial Infarction , 2003 .
[19] B. Pitt,et al. The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure , 2000 .
[20] B. Pitt,et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. , 1999, The New England journal of medicine.
[21] D. Bates,et al. Approximations to the Log-Likelihood Function in the Nonlinear Mixed-Effects Model , 1995 .
[22] J. Vandenbossche,et al. Predictors of early death after acute myocardial infarction: two months follow-up. , 1986, European heart journal.
[23] K Y Liang,et al. Longitudinal data analysis for discrete and continuous outcomes. , 1986, Biometrics.
[24] K. Hammermeister,et al. Variables predictive of survival in patients with coronary disease. Selection by univariate and multivariate analyses from the clinical, electrocardiographic, exercise, arteriographic, and quantitative angiographic evaluations. , 1979, Circulation.
[25] K. Hammermeister,et al. Variables Predictive of Survival in Patients with Coronary Disease: Selection by Univariate and Multivariate Analyses from the Clinical, Electrocardiographic, Exercise, Arteriographic, and Quantitative Angiographic Evaluations , 1979 .
[26] L. Fleisher,et al. Writing Committee Members 3 , 2014 .
[27] Jane A. Linderbaum,et al. ACC/AHA clinical performance measures for adults with ST-elevation and non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures on ST-Elevation and Non-ST-El , 2006, Circulation.
[28] W. Frishman. Sudden Death in Patients With Myocardial Infarction and Left Ventricular Dysfunction, Heart Failure, or Both , 2006 .
[29] R. Becker,et al. Guidelines for the Management of Patients with Acute Myocardial Infarction , 2004, Journal of Thrombosis and Thrombolysis.
[30] B. Pitt,et al. EPLERENONE POST-ACUTE MYOCARDIAL INFARCTION HEART FAILURE EFFICACY AND SURVIVAL STUDY INVESTIGATORS. EPLERENONE, A SELECTIVE ALDOSTERONE BLOCKER, IN PATIENTS WITH LEFT VENTRICULAR DYSFUNCTION AFTER MYOCARDIAL INFARCTION , 2003 .